Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Status:
Completed
Trial end date:
2020-05-20
Target enrollment:
Participant gender:
Summary
This study is a double-blinded, randomized controlled trial to evaluate the efficacy of an
intranasal topical timolol gel in the care for epistaxis in adults with hereditary
hemorrhagic telangiectasia.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Institute of Clinical and Translational Sciences (ICTS)